SCFD1

Sec1 family domain-containing protein 1 · Q8WVM8 · SCFD1 on Sugi Atlas →

0 patent compounds predicted against SCFD1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SCFD1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia PHASE1/PHASE2WITHDRAWN
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer PHASE1/PHASE2COMPLETED
Phase I Study of SC-43 Oral Solution in Subjects With Refractory Solid Tumors PHASE1WITHDRAWN
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer PHASE1COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Dose Escalation Study of Immunomodulatory Nanoparticles PHASE1ACTIVE_NOT_RECRUITING
Glutamine Supplementation in People With Immune Dysregulation EARLY_PHASE1WITHDRAWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
The Genetics of Chiari Type I Malformation nanCOMPLETED
PCD New Gene Discovery nanCOMPLETED
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Molecular Genetic Epidemiology of Endocardial Cushion Defects - SCOR in Pediatric Cardiovascular Disease nanCOMPLETED
Genetic Study of Idiopathic Scoliosis in a Cohort of Families (SCOGEN) nanUNKNOWN
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease nanUNKNOWN
The Influence of Genetic Variations in ELAPOR1 or ELAPOR2 on Insulin Secretion and Glucose Regulation in Humans nanUNKNOWN
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Genetics of Primary Ciliary Dyskinesia nanCOMPLETED
Autophagy Bladder Cancer nanUNKNOWN
Identification of Genetic Basis of Atrioventricular Conduction Defects: From Congenital Forms to Degenerative Forms nanUNKNOWN
The LD Lync Study - Natural History Study of Lipodystrophy Syndromes nanRECRUITING
Study of Skeletal Disorders and Short Stature nanCOMPLETED
Genetic Studies of Inflammatory Bowel Disease nanCOMPLETED
Novel Genetic Disorders of the Immune System nanRECRUITING
Mapping Novel Disease Genes for Dilated Cardiomyopathy nanCOMPLETED
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
Shwachman Diamond Syndrome Registry and Study nanRECRUITING
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages nanCOMPLETED
Identification of a New Gene Involved in Hereditary Lipodystrophy nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SCFD1 binder may also engage these)

ProteinNameSimilarity
Q8BRF7 1.000 Q8BRF7 →
Q62991 1.000 Q62991 →
Q24179 0.998 Q24179 →
O18637 0.995 O18637 →
Q96AX1 0.993 Q96AX1 →
Q9SL48 0.990 Q9SL48 →
Q9D2N9 0.989 Q9D2N9 →
Q63615 0.986 Q63615 →
Q851W1 0.986 Q851W1 →
O74534 0.985 O74534 →
P61763 0.985 P61763 →
STXBP1 Syntaxin-binding protein 1 0.984 landscape →
P61765 0.984 P61765 →
Q5R6D2 0.984 Q5R6D2 →
Q6R748 0.984 Q6R748 →
O08599 0.984 O08599 →
Q07327 0.983 Q07327 →
NAT10 RNA cytidine acetyltransferase 0.983 landscape →
Q15833 0.983 Q15833 →
Q28288 0.981 Q28288 →
Q9W3C1 0.981 Q9W3C1 →
Q94KJ7 0.981 Q94KJ7 →
O93257 0.980 O93257 →
Q28Z41 0.980 Q28Z41 →
O08700 0.980 O08700 →
Q62753 0.979 Q62753 →
P34815 0.979 P34815 →
Q54QC8 0.979 Q54QC8 →
O00186 0.979 O00186 →
P22892 0.978 P22892 →